Skip to main content
. Author manuscript; available in PMC: 2022 Nov 18.
Published in final edited form as: Pediatr Diabetes. 2020 Jan 6;21(2):203–209. doi: 10.1111/pedi.12972

Table 1.

Sample characteristics of the cohort (total sample and by sex; Santiago, Chile). Values represent mean (standard deviation, s.d.), unless indicated otherwise.

Total Sample N=679 Female n = 322 Male n = 357
Age at 16-year evaluation 16.8 (0.3) 16.9 (0.3) 16.8 (0.3)
10y BMI z-score 0.52 (1.02) 0.68 (0.95) 0.83 (0.95)
16y BMI z-score* 0.76 (0.95) 0.61 (0.94) 0.45 (1.08)
Ghrelin 238 (146) 251 (154) 227 (137)
Leptin*** 12.17 (13.74) 19.07 (14.58) 5.93 (9.24)
Adiponectin 11.29 (5.36) 10.28 (4.95) 12.39 (5.57)
L:A *** 1.35 (1.91) 2.01 (2.32) 0.74 (1.17)
HOMA-IR 1.79 (1.32) 1.80 (1.23) 1.78 (1.40)
Elevated BP, %, n** 7%, 50 4%, 12 11%, 38
Low HDL, %, n** 69%, 471 75%, 242 64%, 229
Elevated TG, %, n 8%, 53 8%, 24 8%, 29
Elevated glucose, %, n* 9%, 61 7%, 21 11%, 40
Abdominal obesity, %, n*** 30%, 205 51%, 158 13%, 47
No. of metabolic risk factors 1.2 (0.9) 1.4 (0.9) 1.1 (1.0)
Maternal BMI 29 (5) 29 (5) 29 (5)
*

Values statistically different by sex at P<0.05

**

P<0.01

***

P <0.001.

Note. Appetite hormones and energy regulators were examined by sex and using the 95th percentile cut-off for obesity; IDF criteria used to calculate cutoff values for each metabolic risk factor.

No.: abbreviation for number.